Basilea Pharmaceutica
BSLN.SW
#6418
Rank
A$0.94 B
Marketcap
$77.57
Share price
-2.93%
Change (1 day)
20.46%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.65

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.65. In 2023 the company made an earnings per share (EPS) of $1.65 a decrease over its 2022 EPS that were of $1.77.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.65-6.28%
2022$1.77-273.94%
2021-$1.02-60.87%
2020-$2.59-24.46%
2019-$3.43-26.92%
2018-$4.7059.83%
2017-$2.94-63.06%
2016-$7.96-19.26%
2015-$9.8646.12%
2014-$6.7510.07%
2013-$6.13-36.76%
2012-$9.69-5.42%
2011-$10.25-153.36%
2010$19.20-198.47%
2009-$19.50-15.34%
2008-$23.0316.7%
2007-$19.7436.07%
2006-$14.5079.07%
2005-$8.10-46.79%
2004-$15.229.83%
2003-$13.86-34.23%
2002-$21.07